about the cryptocurrency Top People also ask

Jiangxi-Guangdong Expressway: Contemporary Amperex Technology Co., Limited Jiangxi Zero-carbon Ecological Development Department visited the company to explore new technologies for the construction of "Meilu Expressway". Recently, Qiao Pengfei, general manager of Jiangxi Zero-carbon Ecological Development Department of Contemporary Amperex Technology Co., Limited, and his party visited Jiangxi-Guangdong Expressway to discuss the construction of "Meilu Expressway". Han Feng, Party Secretary and Chairman of Jiangxi-Guangdong Expressway, and Liang Zhiai, member of the Party Committee, attended the discussion, and responsible comrades from relevant departments of both sides attended. Qiao Pengfei introduced Contemporary Amperex Technology Co., Limited's cutting-edge technologies and innovative solutions in the field of low-carbon and zero-carbon, especially its achievements and practical experience in new energy. He said that Contemporary Amperex Technology Co., Limited is committed to providing customized zero-carbon solutions for different industries, and the expressway scene contains huge potential for energy conservation and emission reduction. He hoped that both sides could jointly explore new technologies and new ideas for the construction of "Meilong Expressway" and contribute to the green and low-carbon development of the transportation industry.The newly established enterprise management company in Erdos includes corporate headquarters management business. The enterprise search APP shows that recently, Ordos Dongyu Enterprise Management Co., Ltd. was established, with the legal representative of Chen Houbao and the registered capital of 20 million yuan. Its business scope includes: corporate headquarters management; Technical service, technical development, technical consultation, technical exchange, etc. Enterprise survey shows that the company is wholly owned by Ordos.The Australian dollar's yield on Australian bonds rose. The Australian employment data was better than expected, and the Australian dollar's gains expanded. The previously released data showed that the unemployment rate in Australia unexpectedly fell last month, which cooled the speculation surrounding the Australian central bank's interest rate cut. AUD/USD rose 0.7% to 0.6412; Report 0.6378 before data release. The yield of 3-year Australian government bonds rose from 3.75% before the data was released to 3.79%.

Brother Technology: PEEK is a key application field of hydroquinone, and the company is still in the promotion stage. Brother Technology (002562) said on the interactive platform that the company's hydroquinone products are mainly sold to domestic mainstream acrylic acid producers, and PEEK is a key application field of hydroquinone, and the company is still in the promotion stage; The production capacity of the second phase project of hydroquinone is being released as planned. At present, the company has a production capacity of 20,000 tons of catechol and hydroquinone. Regarding the industrial chain extension plan, the company will carry out relevant work according to the strategic plan and disclose information in time according to the requirements of information disclosure.The central parity of RMB against the US dollar was reported at 7.1854 yuan, down by 11 points.Xinwei International (00058.HK) once rose by 90% when it resumed trading, but now the increase has narrowed to less than 50%.

Central Bank: On December 18th, 20 billion yuan of central bank bills will be issued. On December 18th, the People's Bank of China will issue the 12th issue of central bank bills in 2024 through the CMU bond bidding platform of the Hong Kong Monetary Authority. The 12th central bank bill has a maturity of 6 months (182 days), and is a fixed-rate interest-bearing bond, with a circulation of RMB 20 billion. The value date is December 20, 2024, and the maturity date is June 20, 2025, and the maturity date will be postponed in case of a holiday.Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.According to the information on the suspension and resumption of trading of the Shanghai Stock Exchange, Hasen shares were not announced due to important matters, and they were suspended all day on December 12.